Technology, Not Just Biology, Will Deliver The Future Of Medicine

By Mike Paglia, Chief Technology Officer

Cell and gene therapies hold transformative promise, yet scaling their production remains a persistent bottleneck. Bridging the gap between lab breakthroughs and widespread commercial access requires treating advanced therapies as both biological and engineering challenges. Standardizing production processes, leveraging modular automation, and integrating real-time analytics streamline manufacture, drastically reducing batch variability and lead times. When digital tracking and scalable vector platforms intersect, developers accelerate regulatory pathways and improve yield consistency. Embracing standardized technological infrastructure transforms custom manufacturing into a repeatable, high-throughput science.

Explore how integrating scalable platforms speeds time-to-market and expands patient access to life-changing therapies.